A research team at the University of Wisconsin-Madison produced high-resolution images of RSV structure, important for RSV ...

Infants are among the most susceptible to respiratory complications from respiratory syncytial virus, or RSV. While they can ...

Moderna (MRNA) stock gains as company posts better than expected Q3 results driven by its updated COVID-19 vaccine. Read more ...

The biotech company, which makes the Spikevax RNA-based Covid-19 vaccine, reported net income of $13 million, or 3 cents a share, compared with a loss of $3.6 billion, or $9.53 a share, in the same ...

Respiratory syncytial virus (RSV) is a negative-stranded, RNA-based respiratory paramyxovirus with ten genes encoding 11 proteins. Three proteins are present in the viral envelope, including the ...

Moderna Chief Human Resources Officer Tracey Franklin has expanded her role to Chief People and Digital Technology Officer, overseeing the Company's talent and digital functions. Brad Miller, Chief ...

It occurs in about one in 10 children after a viral infection such as a rhinovirus or respiratory syncytial virus infection and ... of ciliary motion and structure. Clinical suspicion of PCD ...

Do you know a “master of metamorphosis”? A scholar, some time ago, thus defined the influenza virus. Because it changes.

EvolutionaryScale can design proteins with desired properties according to prompts by simultaneously evolving sequence, ...

Pfizer today announced that its respiratory syncytial virus (RSV) vaccine Abrysvo maintained high efficacy ... genes (ARGs), virulence-associated genes (VAGs), and population structure using ...

(Reuters) -Pfizer CEO Albert Bourla, under pressure from activist hedge fund Starboard Value, made his case to Wall Street on Tuesday that the drugmaker's turnaround is succeeding after it reported a ...

In life, there’s a common expression that also carries over into the dividend investing world: If it seems too good to be true, it usually is ...